AntAngioCOOL: An R Package for Computational Detection of Anti-Angiogenic Peptides

Angiogenesis inhibition research is a cutting edge in angiogenesis-dependent disease therapy, and especially in cancer therapy. Recently, studies on anti-angiogenic peptides have provided promising results in the cancer treatment field. In the current study we propose an effective machine learning based R package (AntAngioCOOL) to predict anti-angiogenic peptides. We have examined more than 200 different classifiers to build an efficient predictor. Also, more than 17000 features have been extracted to encode the peptides. However, finally, more than 2000 informative features have been selected to train the classifiers. According to the obtained results AntAngioCOOL can effectively predict anti-angiogenic peptides: this tool achieved sensitivity of 88%, specificity of 77% and accuracy of 75% on independent test set. AntAngioCOOL can be accessed at https://cran.r-project.org/.

[1]  Zhihua Lin,et al.  QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors , 2011, Journal of Molecular Modeling.

[2]  Rong Wang,et al.  Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.

[3]  T. Stegmann.  FGF-1: a human growth factor in the induction of neoangiogenesis. , 1998, Expert opinion on investigational drugs.

[4]  H. T. Yang,et al.  What makes vessels grow with exercise training? , 2004, Journal of applied physiology.

[5]  Kumardeep Chaudhary,et al.  An in silico platform for predicting, screening and designing of antihypertensive peptides , 2015, Scientific Reports.

[6]  M. Messi,et al.  Type-2 pericytes participate in normal and tumoral angiogenesis. , 2014, American journal of physiology. Cell physiology.

[7]  Reza Ebrahimpour,et al.  LocFuse: human protein-protein interaction prediction via classifier fusion using protein localization information. , 2014, Genomics.

[8]  Minoru Kanehisa,et al.  AAindex: amino acid index database, progress report 2008 , 2007, Nucleic Acids Res..

[9]  C. Patra,et al.  Therapeutic application of anti-angiogenic nanomaterials in cancers. , 2016, Nanoscale.

[10]  Chen Chu,et al.  Prediction and analysis of cell-penetrating peptides using pseudo-amino acid composition and random forest models , 2015, Amino Acids.

[11]  B. Rueda,et al.  Tumor Angiogenesis Regulators , 2013 .

[12]  Susan M. Bridges,et al.  Prediction of Cell Penetrating Peptides by Support Vector Machines , 2011, PLoS Comput. Biol..

[13]  R O Bonow,et al.  Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. , 2000, Circulation.

[14]  L. Ricci-Vitiani,et al.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.

[15]  Manoj Kumar,et al.  Prediction and Analysis of Quorum Sensing Peptides Based on Sequence Features , 2015, PloS one.

[16]  S. Venkatesan,et al.  AntiAngioPred: A Server for Prediction of Anti-Angiogenic Peptides , 2015, PloS one.

[17]  A. Schneider,et al.  [Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease]. , 2000, Herz.

[18]  Rahul Kumar,et al.  In Silico Approach for Predicting Toxicity of Peptides and Proteins , 2013, PloS one.

[19]  J. Folkman,et al.  Angiogenic therapy of the human heart. , 1998, Circulation.

[20]  J. Montani,et al.  Overview of Angiogenesis , 2010 .

[21]  Kumardeep Chaudhary,et al.  Cell Penetrating Peptides , 2016 .

[22]  Max Kuhn,et al.  The caret Package , 2007 .

[23]  M. Messi,et al.  Pericytes at the intersection between tissue regeneration and pathology. , 2015, Clinical science.

[24]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[25]  P. Maini,et al.  Mesoscopic and continuum modelling of angiogenesis , 2014, Journal of mathematical biology.

[26]  K. Chou.  Prediction of protein cellular attributes using pseudo‐amino acid composition , 2001, Proteins.